Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

SQZ Biotechnologies Company

SQZB
Current price
0.04 USD 0 USD (0.00%)
Last closed 0.043 USD
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange PINK
Capitalization 1 179 644 USD
Yield for 12 month -57.45 %
1Y
3Y
5Y
10Y
15Y
SQZB
21.11.2021 - 28.11.2021

SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. The Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts. Address: 200 Arsenal Yards Boulevard, Watertown, MA, United States, 02472

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

22 USD

P/E ratio

Dividend Yield

Current Year

+12 196 000 USD

Last Year

+21 478 000 USD

Current Quarter

Last Quarter

+178 000 USD

Current Year

Last Year

+9 794 000 USD

Current Quarter

-2 229 000 USD

Last Quarter

-2 070 000 USD

Key Figures SQZB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -59 061 000 USD
Operating Margin TTM -501.34 %
PE Ratio
Return On Assets TTM -41.14 %
PEG Ratio
Return On Equity TTM -203.37 %
Wall Street Target Price 22 USD
Revenue TTM 12 121 000 USD
Book Value 0.064 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -94.5 %
Dividend Yield
Gross Profit TTM
Earnings per share -2.43 USD
Diluted Eps TTM -2.43 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics SQZB

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History SQZB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:10
Payout Ratio
Last Split Date 07.07.2023
Dividend Date

Stock Valuation SQZB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.0215
Price Sales TTM 0.0973
Enterprise Value EBITDA -0.0052
Price Book MRQ 0.6271

Financials SQZB

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators SQZB

For 52 weeks

0.01 USD 0.12 USD
50 Day MA 0.052 USD
Shares Short Prior Month 743 030
200 Day MA 0.04 USD
Short Ratio 27.26
Shares Short 811 150
Short Percent 3.03 %